A 400-patient study completed; the paper is under review (demo).
Pulsewell · Sep 2026Loading market
Demo market. Pulsewell, its founders and every number on this page are fictional, made to demonstrate Mitra. This content is illustrative. Exchange prices and volume include only actual executions; this market cannot accept real orders.
—Last trade
Yes No offerNo No offerOpen
No resting orders. No executable quote is available.
Pulsewell, founded by Dr. Samuel Okoye, makes a 14-day adhesive heart-rhythm monitor that flags atrial fibrillation and sends reports straight to the patient's clinician.
A thin patch records a continuous ECG for 14 days. Pulsewell's software flags suspected atrial fibrillation and other arrhythmias, and a clinician portal lets doctors review the strips.
Samuel is a cardiologist who got tired of patients missing their arrhythmia on a 24-hour monitor. Practicing cardiologist for ten years; led a hospital's remote-monitoring program.
A 400-patient study completed; the paper is under review (demo).
UnverifiedPulsewell filed a 510(k) premarket notification (demo).
Founder-reportedThese legacy terms need owner review and republication before any funded contract could open. Missing or unavailable source data is never treated as No. No orders can be executed.
Only the Mitra owner settles markets, from the source above. Founders cannot trade, settle or change their own markets. Each ruling has a 24-hour window for objections before payout.
A 400-patient study completed; the paper is under review (demo).
Pulsewell · Sep 2026
Cameron N.@demo_cameronnDemo12d
If they keep this pace, Yes looks cheap.
Jordan S.@demo_jordansDemo3mo
Bought Yes at 28¢. The demo video sold me.